POSTACIE SOLI MEGLUMINOWEJ KWASU 2-((1R,4R)-4-(4-(5-(BENZOKSAZOL-2-ILOAMINO)PIRYDYN-2-YLO)FENYLO)CYKLOHEKSYLO)OCTOWEGO I ICH ZASTOSOWANIA JAKO INHIBITORY DGAT1

• 收藏
• 分享

专利权人:

Novartis AG

发明人:

CAPACCI-DANIEL, CHRISTINA,DELACRUZ, MARILYN,GONG, BAOQING,JAIN, AKASH,LU, YANSONG,ZHANG, LIJUN

申请号：

PL14701273

公开号：

PL2943488T3

申请日:

2014.01.10

申请国别(地区):

PL

年份:

2018

代理人:

摘要：

The present invention relates to novel crystalline forms of salts of 2-((1R,4R)-4-(4-(5-(benzo[d]oxazol-2-ylamino)pyridin-2-yl)phenyl)cyclohexyl)acetic acid and their use in the treatment or prevention of a condition or a disorder associated with DGAT1 activity in animals, particularly humans.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/